Published in Pediatr Infect Dis J on January 01, 2006
Incidence of rotavirus infection in children with gastroenteritis attending Jos university teaching hospital, Nigeria. Virol J (2011) 1.08
Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study. BMC Infect Dis (2010) 1.03
Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001-2005. BMC Public Health (2008) 0.97
Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom. Epidemiol Infect (2007) 0.96
Epidemiology of rotavirus-associated hospital admissions in the province of Ferrara, Italy. Eur J Pediatr (2009) 0.90
Incidence and cost of rotavirus hospitalizations in Denmark. Emerg Infect Dis (2007) 0.85
Hospitalizations due to rotavirus gastroenteritis in Catalonia, Spain, 2003-2008. BMC Res Notes (2011) 0.83
Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective. Vaccine (2011) 0.82
Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study. Confl Health (2015) 0.78
Therapeutics Insight with Inclusive Immunopharmacology Explication of Human Rotavirus A for the Treatment of Diarrhea. Front Pharmacol (2016) 0.76
Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: the ROTACOST study. BMC Pediatr (2011) 0.75
The Prevalence of Rotavirus and Adenovirus in the Childhood Gastroenteritis. Jundishapur J Microbiol (2016) 0.75
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis (2011) 3.04
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf (2010) 2.57
Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS (2006) 2.26
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med (2009) 2.16
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis (2011) 2.13
Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis (2007) 1.99
Drug use in children: cohort study in three European countries. BMJ (2008) 1.91
Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics (2005) 1.55
Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J (2006) 1.54
Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS (2009) 1.49
Effects of nutritional rehabilitation on intestinal function and on CD4 cell number in children with HIV. J Pediatr Gastroenterol Nutr (2002) 1.43
Intussusception among young children in Europe. Pediatr Infect Dis J (2006) 1.42
Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect (2011) 1.40
Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. AIDS (2007) 1.28
Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study. BMC Fam Pract (2010) 1.24
Assessment of pediatric asthma drug use in three European countries; a TEDDY study. Eur J Pediatr (2010) 1.19
Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infect Dis (2012) 1.16
Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy. BMC Infect Dis (2009) 1.14
Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS (2002) 1.14
Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study. J Infect Dis (2007) 1.13
Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1. Pediatr Infect Dis J (2003) 1.13
Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther (2008) 1.13
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project. J Am Med Inform Assoc (2012) 1.09
Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res (2008) 1.08
Older children and adolescents surviving with vertically acquired HIV infection. J Acquir Immune Defic Syndr (2002) 1.07
Databases for pediatric medicine research in Europe--assessment and critical appraisal. Pharmacoepidemiol Drug Saf (2008) 1.07
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. Stud Health Technol Inform (2011) 1.06
Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy. J Infect Dis (2006) 1.05
Pregnancy and HIV infection: A european consensus on management. AIDS (2002) 1.04
Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J (2006) 1.01
Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009. BMC Infect Dis (2011) 0.99
The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands. Pharmacol Res (2010) 0.98
Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Transl Med (2010) 0.98
Clinical trials of rotavirus vaccines in Europe. Pediatr Infect Dis J (2006) 0.98
Comparison of antiepileptic drug prescribing in children in three European countries. Epilepsia (2009) 0.97
Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents. AIDS (2008) 0.96
European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary. J Pediatr Gastroenterol Nutr (2008) 0.96
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up. Pediatr Infect Dis J (2014) 0.95
Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Public Health (2011) 0.95
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women. AIDS (2013) 0.93
Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries. Drug Saf (2013) 0.93
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. PLoS One (2013) 0.92
Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children. AIDS (2012) 0.92
A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). Arch Dis Child (2011) 0.91
Innovative study design for paediatric clinical trials. Eur J Clin Pharmacol (2011) 0.90
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants. AIDS (2013) 0.90
Role of beta-defensin-1 polymorphisms in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr (2009) 0.89
Recommendations for rotavirus vaccination: A worldwide perspective. Vaccine (2010) 0.89
Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR project. Stud Health Technol Inform (2010) 0.89
Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau. BMC Infect Dis (2011) 0.89
Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions. Hum Vaccin Immunother (2012) 0.89
European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr (2008) 0.89
Varicella vaccination in Italy : an economic evaluation of different scenarios. Pharmacoeconomics (2004) 0.89
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration. J Antimicrob Chemother (2006) 0.88
HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children. PLoS One (2008) 0.88
Cancer rates after year 2000 significantly decrease in children with perinatal HIV infection: a study by the Italian Register for HIV Infection in Children. J Clin Oncol (2007) 0.88
Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy. Virol J (2010) 0.87
A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project. Stud Health Technol Inform (2009) 0.87
The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection. BMC Infect Dis (2014) 0.87
European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014. Pediatr Infect Dis J (2015) 0.87
Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. Drug Saf (2014) 0.86
Rotavirus. J Pediatr Gastroenterol Nutr (2008) 0.86
The incidence of varicella: correction of a common error. Epidemiology (2003) 0.86
Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1. Antimicrob Agents Chemother (2005) 0.86
Post-licensing safety of fosamprenavir in HIV-infected children in Europe. Pharmacoepidemiol Drug Saf (2014) 0.86
Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1? Clin Infect Dis (2009) 0.86
Burden of acute otitis media in primary care pediatrics in Italy: a secondary data analysis from the Pedianet database. BMC Pediatr (2012) 0.84
Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age. Br J Clin Pharmacol (2011) 0.84
Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: results from a phase 2 open-label trial (DIONE). Pediatr Infect Dis J (2014) 0.84
Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr (2014) 0.84
The Task-force in Europe for Drug Development for the Young (TEDDY) Network of Excellence. Paediatr Drugs (2009) 0.83
Role of non-nucleoside reverse transcriptase inhibitors in treating HIV-infected children. Drugs (2011) 0.81
Update on antiretroviral therapy in paediatrics. Antiviral Res (2009) 0.80
The role of genetic variants of Stromal cell-Derived Factor 1 in pediatric HIV-1 infection and disease progression. PLoS One (2012) 0.80
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. Antivir Ther (2013) 0.79
Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents. AIDS (2012) 0.79
Premature aging and immune senescence in HIV-infected children. AIDS (2016) 0.78
European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives. J Int Bioethique (2008) 0.78
Programmatic impact of the evolution of WHO pediatric antiretroviral treatment guidelines for resource-limited countries (Tukula Fenna Project, Uganda). J Acquir Immune Defic Syndr (2012) 0.78
Withdrawal of Pneumocystis jirovecii prophylaxis in HIV-infected children under highly active antiretroviral therapy. AIDS (2005) 0.78
Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands. Pediatr Infect Dis J (2014) 0.78
Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience. J Acquir Immune Defic Syndr (2016) 0.77
Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa. Expert Rev Vaccines (2015) 0.76
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial. Antivir Ther (2006) 0.76
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children. AIDS Behav (2013) 0.75
Comment on the contribution by Weycker et al., "Cost of routine immunization of young children against rotavirus infection with Rotarix ® versus RotaTeq ®". Vaccine (2010) 0.75
Atazanavir exposure is effective during pregnancy regardless of tenofovir use. Antivir Ther (2014) 0.75
Intrafamilial transmission of HIV-1. AIDS (2003) 0.75
Co-infection with HIV and HCV in 229 children and young adults living in Europe. AIDS (2016) 0.75
Using Prescription Patterns in Primary Care to Derive New Quality Indicators for Childhood Community Antibiotic Prescribing. Pediatr Infect Dis J (2016) 0.75
Risk of perinatal HIV infection in infants born in Italy to immigrant mothers. Clin Infect Dis (2011) 0.75
Antiretroviral use in Italian children with perinatal HIV infection over a 14-year period. Acta Paediatr (2012) 0.75
The Challenge of Treating Children with Hepatitis C Virus Infection. J Pediatr Gastroenterol Nutr (2017) 0.75